ArticleMolecular therapy. Methods & clinical development2022

CRISPR-Cas9-mediated gene disruption of HIV-1 co-receptors confers broad resistance to infection in human T cells and humanized mice.

Shasha Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.